Cover Image
Market Research Report

Small Molecule Drug Discovery - Global Market Outlook (2017-2026)

Published by Stratistics Market Research Consulting Product code 771654
Published Content info 212 Pages
Delivery time: 2-3 business days
Price
Back to Top
Small Molecule Drug Discovery - Global Market Outlook (2017-2026)
Published: December 1, 2018 Content info: 212 Pages
Description

According to Stratistics MRC, the Global Small Molecule Drug Discovery Market is expected to grow at a CAGR of 8.5% during the forecast period. Some of the factors such as rise in drug discovery and development and rising usage of these drugs in the treatment of chronic diseases are driving the market growth. However, high costs of drugs are hindering the market growth.

Small molecule drug is a substance that can quickly enter the cells due to its low molecular weight. After entering the cells, it may affect the other molecules like proteins and may cause the cancer cells to die. There are two phases of developing new small molecule drugs. One is Drug discovery, and the other one is Drug development. Small molecule drugs are different from other drugs which have a large molecular weight. So, these targeted therapies are small-molecule drugs or small molecule inhibitors.

By Process Phase, lead optimization segment held significant growth during the forecast period due to increasing strength, selectivity, or pharmacokinetic parameters, rising in cancer and other diseases encouraging investments in lead optimization. Based on geography, North America is anticipated to be one of the leading regions contributing to the global market during the forecast period. There is an increasing number of contract organizations for research and development. This shows that the United States is focusing on R&D activities to meet the rising demands of its people, finally leading the market of North America.

Some of the key players profiled in the Small Molecule Drug Discovery Market include Astrazeneca, Boehringer Ingelheim Gmbh, Bristol- Myers Squibb, Gilead Sciences, Inc., Glaxosmithkline, Johnson & Johnson, Merck & Co., Pfizer Inc and Teva Pharmaceuticals.

Process Phases Covered:

  • Hit Generation and Selection
  • Lead Identification
  • Lead Optimization
  • Target Id/Validation

Therapeutic Areas Covered:

  • Anti-Infective
  • Cardiovascular
  • Central Nervous System
  • Dermatology
  • Gastrointestinal
  • Immunological
  • Metabolic
  • Oncology
  • Orthopedics
  • Respiratory
  • Other Therapeutic Areas

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
Table of Contents

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Small Molecule Drug Discovery Market, By Process Phase

  • 5.1 Introduction
  • 5.2 Hit Generation and Selection
  • 5.3 Lead Identification
  • 5.4 Lead Optimization
  • 5.5 Target Id/Validation

6 Global Small Molecule Drug Discovery Market, By Therapeutic Area

  • 6.1 Introduction
  • 6.2 Anti-Infective
  • 6.3 Cardiovascular
  • 6.4 Central Nervous System
  • 6.5 Dermatology
  • 6.6 Gastrointestinal
  • 6.7 Immunological
  • 6.8 Metabolic
  • 6.9 Oncology
  • 6.10 Orthopedics
  • 6.11 Respiratory
  • 6.12 Other Therapeutic Areas

7 Global Small Molecule Drug Discovery Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Astrazeneca
  • 9.2 Boehringer Ingelheim Gmbh
  • 9.3 Bristol- Myers Squibb
  • 9.4 Gilead Sciences, Inc.
  • 9.5 Glaxosmithkline
  • 9.6 Johnson & Johnson
  • 9.7 Merck & Co.
  • 9.8 Pfizer Inc
  • 9.9 Teva Pharmaceuticals

List of Tables

  • Table 1 Global Small Molecule Drug Discovery Market Outlook, By Region (2016-2026) (US $MN)
  • Table 2 Global Small Molecule Drug Discovery Market Outlook, By Process Phase (2016-2026) (US $MN)
  • Table 3 Global Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2016-2026) (US $MN)
  • Table 4 Global Small Molecule Drug Discovery Market Outlook, By Lead Identification (2016-2026) (US $MN)
  • Table 5 Global Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2016-2026) (US $MN)
  • Table 6 Global Small Molecule Drug Discovery Market Outlook, By Target Id/Validation (2016-2026) (US $MN)
  • Table 7 Global Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2016-2026) (US $MN)
  • Table 8 Global Small Molecule Drug Discovery Market Outlook, By Anti-Infective (2016-2026) (US $MN)
  • Table 9 Global Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 10 Global Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2016-2026) (US $MN)
  • Table 11 Global Small Molecule Drug Discovery Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 12 Global Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2016-2026) (US $MN)
  • Table 13 Global Small Molecule Drug Discovery Market Outlook, By Immunological (2016-2026) (US $MN)
  • Table 14 Global Small Molecule Drug Discovery Market Outlook, By Metabolic (2016-2026) (US $MN)
  • Table 15 Global Small Molecule Drug Discovery Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 16 Global Small Molecule Drug Discovery Market Outlook, By Orthopedics (2016-2026) (US $MN)
  • Table 17 Global Small Molecule Drug Discovery Market Outlook, By Respiratory (2016-2026) (US $MN)
  • Table 18 Global Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2016-2026) (US $MN)
  • Table 19 North America Small Molecule Drug Discovery Market Outlook, By Country (2016-2026) (US $MN)
  • Table 20 North America Small Molecule Drug Discovery Market Outlook, By Process Phase (2016-2026) (US $MN)
  • Table 21 North America Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2016-2026) (US $MN)
  • Table 22 North America Small Molecule Drug Discovery Market Outlook, By Lead Identification (2016-2026) (US $MN)
  • Table 23 North America Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2016-2026) (US $MN)
  • Table 24 North America Small Molecule Drug Discovery Market Outlook, By Target Id/Validation (2016-2026) (US $MN)
  • Table 25 North America Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2016-2026) (US $MN)
  • Table 26 North America Small Molecule Drug Discovery Market Outlook, By Anti-Infective (2016-2026) (US $MN)
  • Table 27 North America Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 28 North America Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2016-2026) (US $MN)
  • Table 29 North America Small Molecule Drug Discovery Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 30 North America Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2016-2026) (US $MN)
  • Table 31 North America Small Molecule Drug Discovery Market Outlook, By Immunological (2016-2026) (US $MN)
  • Table 32 North America Small Molecule Drug Discovery Market Outlook, By Metabolic (2016-2026) (US $MN)
  • Table 33 North America Small Molecule Drug Discovery Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 34 North America Small Molecule Drug Discovery Market Outlook, By Orthopedics (2016-2026) (US $MN)
  • Table 35 North America Small Molecule Drug Discovery Market Outlook, By Respiratory (2016-2026) (US $MN)
  • Table 36 North America Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2016-2026) (US $MN)
  • Table 37 Europe Small Molecule Drug Discovery Market Outlook, By Country (2016-2026) (US $MN)
  • Table 38 Europe Small Molecule Drug Discovery Market Outlook, By Process Phase (2016-2026) (US $MN)
  • Table 39 Europe Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2016-2026) (US $MN)
  • Table 40 Europe Small Molecule Drug Discovery Market Outlook, By Lead Identification (2016-2026) (US $MN)
  • Table 41 Europe Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2016-2026) (US $MN)
  • Table 42 Europe Small Molecule Drug Discovery Market Outlook, By Target Id/Validation (2016-2026) (US $MN)
  • Table 43 Europe Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2016-2026) (US $MN)
  • Table 44 Europe Small Molecule Drug Discovery Market Outlook, By Anti-Infective (2016-2026) (US $MN)
  • Table 45 Europe Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 46 Europe Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2016-2026) (US $MN)
  • Table 47 Europe Small Molecule Drug Discovery Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 48 Europe Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2016-2026) (US $MN)
  • Table 49 Europe Small Molecule Drug Discovery Market Outlook, By Immunological (2016-2026) (US $MN)
  • Table 50 Europe Small Molecule Drug Discovery Market Outlook, By Metabolic (2016-2026) (US $MN)
  • Table 51 Europe Small Molecule Drug Discovery Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 52 Europe Small Molecule Drug Discovery Market Outlook, By Orthopedics (2016-2026) (US $MN)
  • Table 53 Europe Small Molecule Drug Discovery Market Outlook, By Respiratory (2016-2026) (US $MN)
  • Table 54 Europe Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2016-2026) (US $MN)
  • Table 55 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Country (2016-2026) (US $MN)
  • Table 56 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Process Phase (2016-2026) (US $MN)
  • Table 57 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2016-2026) (US $MN)
  • Table 58 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Lead Identification (2016-2026) (US $MN)
  • Table 59 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2016-2026) (US $MN)
  • Table 60 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Target Id/Validation (2016-2026) (US $MN)
  • Table 61 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2016-2026) (US $MN)
  • Table 62 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Anti-Infective (2016-2026) (US $MN)
  • Table 63 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 64 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2016-2026) (US $MN)
  • Table 65 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 66 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2016-2026) (US $MN)
  • Table 67 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Immunological (2016-2026) (US $MN)
  • Table 68 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Metabolic (2016-2026) (US $MN)
  • Table 69 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 70 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Orthopedics (2016-2026) (US $MN)
  • Table 71 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Respiratory (2016-2026) (US $MN)
  • Table 72 Asia Pacific Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2016-2026) (US $MN)
  • Table 73 South America Small Molecule Drug Discovery Market Outlook, By Country (2016-2026) (US $MN)
  • Table 74 South America Small Molecule Drug Discovery Market Outlook, By Process Phase (2016-2026) (US $MN)
  • Table 75 South America Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2016-2026) (US $MN)
  • Table 76 South America Small Molecule Drug Discovery Market Outlook, By Lead Identification (2016-2026) (US $MN)
  • Table 77 South America Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2016-2026) (US $MN)
  • Table 78 South America Small Molecule Drug Discovery Market Outlook, By Target Id/Validation (2016-2026) (US $MN)
  • Table 79 South America Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2016-2026) (US $MN)
  • Table 80 South America Small Molecule Drug Discovery Market Outlook, By Anti-Infective (2016-2026) (US $MN)
  • Table 81 South America Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 82 South America Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2016-2026) (US $MN)
  • Table 83 South America Small Molecule Drug Discovery Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 84 South America Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2016-2026) (US $MN)
  • Table 85 South America Small Molecule Drug Discovery Market Outlook, By Immunological (2016-2026) (US $MN)
  • Table 86 South America Small Molecule Drug Discovery Market Outlook, By Metabolic (2016-2026) (US $MN)
  • Table 87 South America Small Molecule Drug Discovery Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 88 South America Small Molecule Drug Discovery Market Outlook, By Orthopedics (2016-2026) (US $MN)
  • Table 89 South America Small Molecule Drug Discovery Market Outlook, By Respiratory (2016-2026) (US $MN)
  • Table 90 South America Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2016-2026) (US $MN)
  • Table 91 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Country (2016-2026) (US $MN)
  • Table 92 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Process Phase (2016-2026) (US $MN)
  • Table 93 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Hit Generation and Selection (2016-2026) (US $MN)
  • Table 94 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Lead Identification (2016-2026) (US $MN)
  • Table 95 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Lead Optimization (2016-2026) (US $MN)
  • Table 96 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Target Id/Validation (2016-2026) (US $MN)
  • Table 97 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Therapeutic Area (2016-2026) (US $MN)
  • Table 98 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Anti-Infective (2016-2026) (US $MN)
  • Table 99 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 100 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Central Nervous System (2016-2026) (US $MN)
  • Table 101 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 102 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Gastrointestinal (2016-2026) (US $MN)
  • Table 103 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Immunological (2016-2026) (US $MN)
  • Table 104 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Metabolic (2016-2026) (US $MN)
  • Table 105 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 106 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Orthopedics (2016-2026) (US $MN)
  • Table 107 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Respiratory (2016-2026) (US $MN)
  • Table 108 Middle East & Africa Small Molecule Drug Discovery Market Outlook, By Other Therapeutic Areas (2016-2026) (US $MN)
Back to Top